Guaifenesin and Dextromethorphan HBr Tablets, 400 mg/20 mg

Manufacturer
Yichang Humanwell Pharmaceutical Co. Ltd.
Effective date
2017-04-21
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 01:16:31

Label at a glance#

ProductGuaifenesin and Dextromethorphan Hydrobromide
Active ingredientDEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN
Label structure7 sections

Indications and uses

■Temporarily relieves cough due to minor throat and bronchial irritation as may occur with a common cold ■Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus ■Helps make coughs more productive.

Dosage and administration

■ Adults and children 12 years and over: take 1 tablet every 4 hours as needed ■ Children 6 to under 12 years: take 1/2 tablet every 4 hours as needed ■ Children under 6 years: consult a doctor Do not exceed 6 doses in a 24 hour period or as directed by a doctor

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredient (per tablet) Purpose
Dextromethorphan Hydrobromide 20mgCough Suppressant
Guaifenesin 400mgExpectorant

Uses

INDICATIONS & USAGE SECTION

■Temporarily relieves cough due to minor throat and bronchial irritation as may occur with a common cold

■Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus

■Helps make coughs more productive.

Warnings

WARNINGS SECTION

Do not use

■ if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease) or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains a MAOI, ask a doctor or pharmacist before using this product.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

■ persistent or chronic cough, such as occurs with smoking, asthma, chronic bronchitis, or emphysema

■ cough that is accompanied by excessive phlegm (mucus)

OTC - STOP USE SECTION

Stop use and ask a doctor if

■ symptoms are accompanied by fever, rash, or persistent headache

■ cough persists for more than 1 week or tends to recur.

A persistent cough may be a sign of a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OVERDOSAGE SECTION

In case of overdose, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

■ Adults and children 12 years and over: take 1 tablet every 4 hours as needed

■ Children 6 to under 12 years: take 1/2 tablet every 4 hours as needed

■ Children under 6 years: consult a doctor

Do not exceed 6 doses in a 24 hour period or as directed by a doctor

Other information

HOW SUPPLIED SECTION

■ store at USP controlled room remperature

■ protect from heat, humidity, and light

INACTIVE INGREDIENT SECTION

Inactive ingredientscolloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone and sodium starch glycolate.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label for DMlabel for DM

90099009

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62732-900962732-9009-1, 62732-9009-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d108c36a-6a06-2793-e053-2995a90ae0593d233b7c-1f46-5fd7-e054-00144ff8d46c2021-11-17WarningsExact identifier
spl set id: 3d233b7c-1f46-5fd7-e054-00144ff8d46c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.